KALRAXXI Trademark

Trademark Overview

On Wednesday, December 9, 2015, a trademark application was filed for KALRAXXI with the United States Patent and Trademark Office. The USPTO has given the KALRAXXI trademark a serial number of 86843912. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 29, 2019. This trademark is owned by Merck Sharp & Dohme Corp.. The KALRAXXI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology
kalraxxi

General Information

Serial Number86843912
Word MarkKALRAXXI
Filing DateWednesday, December 9, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 29, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 12, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Monday, July 29, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 29, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 4, 2018EXTENSION 5 GRANTED
Monday, November 26, 2018EXTENSION 5 FILED
Tuesday, December 4, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 26, 2018TEAS EXTENSION RECEIVED
Wednesday, June 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 11, 2018EXTENSION 4 GRANTED
Monday, June 11, 2018EXTENSION 4 FILED
Monday, June 11, 2018TEAS EXTENSION RECEIVED
Wednesday, November 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2017EXTENSION 3 GRANTED
Monday, November 27, 2017EXTENSION 3 FILED
Monday, November 27, 2017TEAS EXTENSION RECEIVED
Friday, October 6, 2017ASSIGNED TO EXAMINER
Tuesday, June 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 9, 2017EXTENSION 2 GRANTED
Friday, June 9, 2017EXTENSION 2 FILED
Friday, June 9, 2017TEAS EXTENSION RECEIVED
Thursday, December 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2016EXTENSION 1 GRANTED
Tuesday, December 6, 2016EXTENSION 1 FILED
Tuesday, December 6, 2016TEAS EXTENSION RECEIVED
Tuesday, June 28, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 26, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 26, 2016ASSIGNED TO EXAMINER
Saturday, December 12, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 12, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

kalraxxi oncology preparations pharmaceutical